CenTrial Logo

Reboxetine May Reduce Obstructive Sleep Apnea Severity


Clinical trial finds that Reboxetine may reduce the severity of obstructive sleep apnea

Obstructive sleep apnea (OSA) is a sleep disorder that causes a person to stop breathing repeatedly while they sleep. This happens when the muscles in the back of the throat fail to keep the airway open. People with sleep apnea may wake up tired and have difficulty concentrating during the day. They may also snore loudly or gasp for air during sleep. Sleep apnea can be caused by obesity, alcohol use, and smoking. Treatment options include lifestyle changes, such as losing weight and avoiding alcohol, and using a continuous positive airway pressure (CPAP) machine to keep the airway open during sleep.

Clinical Trial

Research studies suggest that certain chemicals in the body, like noradrenaline and acetylcholine, play important roles in controlling the muscles in the throat that help us breathe. A clinical trial investigated whether a medication called reboxetine, which affects noradrenaline levels in the body, could reduce OSA severity on its own or in combination with another medication called oxybutynin, which affects acetylcholine levels.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me


Sixteen people with OSA participated in the study and received different doses of reboxetine, oxybutynin, or a placebo. Reboxetine alone reduced the number of breathing interruptions by 5.4 events per hour, and the combination of reboxetine and oxybutynin did not provide additional benefits. Reboxetine also improved the levels of oxygen in the blood and the stability of the upper airway during sleep.


These findings provide new insights into how medication can be used to treat OSA and may inform future developments in pharmacotherapy. The study suggests that reboxetine, which affects noradrenaline levels, can reduce OSA severity without needing additional medication.

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Signup to be notified of clinical trials near you that match your condition

Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.